New insight into the biosynthesis of flavanolignans in the white-flowered variant of Silybum marianum

Journal of Chromatographic Science

Volumn 46, Issue 2, 2008, Pages 93-96

  Nyiredy, Sz ^a   Samu, Zs ^b   Szucs Z ^a   Gulacsi K ^c   Kurtan T ^c   Antus, S ^c  

^a Research Institute for Medicinal Plants Budakalasz   (Hungary)

^b Béres Pharmaceuticals Ltd   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

SILYBUM MARIANUM;

EID: 40949146629     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.2.93     Document Type: Article

References (34)

1. K. Westphal. Gallenfuntionen und Gallenleiden. Springer Verlag, Berlin, 1931, p. 306.
2. H. Schindler. Active substances in pharmaceutical plants; methods to determine plant tinctures; contributions to a supplementary issue of the homoiopathic pharmacopeia. Arzneim.-Forsch. (Drug Res.) 2: 291-296 (1952).
3. B. Janiak and R. Hänsel. Phytochemisch-pharmakognostische Untersuchungen über Fructus cardui Mariae. Planta Med. 8: 71-84 (1960).
4. H. Wagner, L. Hörhammer, and M. Seitz. Chemische Wertbestimmung eines Silymarin-haltigen Flavonoidkonzentrates aus Silybum marianum (L.) Gaertn. Arzneim.-Forsch. (Drug Res.) 18: 696-698 (1968).
5. A. Pelter and R. Hänsel. The structure of silybin (silybum substance E6), the first flavonolignan. Tetrahedron Lett. 2911-2916 (1968).
6. H. Wagner, L. Hörhammer, and R. Münster. Zur Chemie des Silymarins (Silybin), des Werkprinzips der Früchte von Silybum marianum (L.) Gaertn. (Carduus marianus L.). Arzneim-Forsch. (Drug Res.) 18: 688-696 (1968).
7. G. Vogel. New Natural Products and Plant Drugs with Pharmacological, Biological and Therapeutical Activity. Springer Verlag, Berlin-Heildelberg-New York, 1977, p. 249.
8. R. Saller, R. Meier, and R. Brignoli. The use of silymarin in the treatment of liver diseases. Drugs 61: 2035-2063 (2001).
9. M. Delfini, M.E. DiCacco, E. Gaggelli, A. Lepri, and G. Valensin. 1H NMR delineation of confromational parameters of constituents of silybum marianum in solution. Spectrosc. Lett. 23: 1007-1025 (1990).
10. H. Lotter and H. Wagner. Zur Stereochemie von Silybin. Z. Naturforsch. 38c: 339-341 (1983).
11. L. Merlini and A. Zanarotti. Biomimetic Synthesis of Natural Silybin. J. Chem. Soc. Chem. Commun. Issue or page numbers required for publication. 695 (1979).
12. L. Merlini, A. Zanarotti, A. Pelter, M.P. Rochefort, and R. Hänsel. Benzodioxans by oxidative phenol coupling. Synthesis of silybin. J. Chem. Soc. Perkin Trans. 1: 775-778 (1980).
13. A. Arnone, L. Merlini, and A. Zanarotti. Constituents of silybum marianum. Structure of isosilybin and stereochemistry of silybin. J. Chem. Soc. Chem. Commun. 696-697 (1979).
14. K. Freudenberg and A.C. Neish. Constitution and Biosynthesis of Lignins. Springer Verlag, New York, 1968.
15. H. Erdtman. Dehydrierungen in der Coniferylreihe. II. Dehydrodiisoengenol. Justus Liebigs Ann. Chem. 503: 283-294 (1933).
16. R. Hänsel and H. Rimpler. Structure of silybin: synthetic studies. Dtsch. Apotk. Ztg. 108: 1985 (1968).
17. R. Schrall and H. Becker. Callus-und Suspensionskulturen von Silybum Marianum. Planta Med. 32: 27-32 (1977).
18. L. Merlini and A. Zanarotti. A biogenetically patterned synthesis of (-)-eusiderin. Tetrahedron Lett. 3621-3622 (1975).
19. G. Tittel and H. Wagner. Hochleistungsflüssigchromatographie von Silymarin. II: Quantitative Bestimmung von Silymarin aus Silybum marianum durch Hochleistungsflüssigchromatographie. J. Chromatogr. 153: 227-232 (1978).
20. H. Mascher, C. Kikuta, and R. Weyhenmeyer. Diastereomeric separation of free and conjugated silibin in plasma by reversed-phase HPLC after specific extraction. J. Liquid Chromatogr. 16: 2777 (1993).
21. B. Rickling, B. Hans, R. Kramarczyk, G. Krumbiegel, and R. Weyhenmeyer. Two high-performance liquid chromatographic assays for the determination of free and total silibinin diastereomers in plasma using column switching with electrochemical detection and reversed-phase chromatography with ultraviolet detection. J. Chromatogr. B 670: 267 (1995).
22. N.C. Kim, T.N. Graf, Ch.M. Sparacino, M.C. Wani, and M.E. Wall. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). Org. Biomol. Chem. 1: 1684-1689 (2003).
23. D.Y.W. Lee and Y. Lin. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, isolated from silybum marianum (Milk Thistle). J. Nat. Prod. 66: 1171-1174 (2003).
24. G. Stiber, I. Szilágyi, and P. Tétényi. Hatóanyagtartalmi és összetételbeli különbségek a Silybum genus két fajában (Silybum marianum (L.) Gaertn és Silybum eburneum coss. et durr.). Herba Hung. 16: 55 (1977).
25. I. Szilágyi, P. Tétényi, S. Antus, O. Seligmann, V.M. Chari, M. Seitz, and H. Wagner. Struktur von Silandrin und Silymonin, zwei neuen Flavanolignanen aus einer weissblühenden Silybum marianum Varietät. Planta Med. 43: 121-127 (1981).
26. Zs. Samu, Sz. Nyiredy, E. Baitz-Gács, Zs. Varga, T. Kurtán, Z. Dinya, and S. Antus. Structure elucidation and antioxidant activity of (-)-isosilandrin Isolated from silybum marianum L. Chem. Biodiversity 1: 1668-1677 (2004).
27. S. Antus, E. Baitz-Gács, G. Snatzke, and T.S. Tóth. Synthesis and circular dichroism of steroids with 1,4-benzodioxane chromophore: on the absolute configuration of (-)-silandrin. Liebigs Ann. Chem. 633-641 (1991).
28. H. Hikino, Y. Kiso, H. Wagner, and M. Fiebig. Antihepatotoxic actions of flavonolignans from silybum marianum fruits. Planta Med. 50: 248-250 (1984).
29. P.R. David-Searles, Y. Nakanashi, N.C. Kim, T.N. Graf, N.H. Oberlies, M.C. Wami, M.E. Wall, R. Agrawal, and D.J. Kroll. Milk thistle and prostate cancer: differential effects of pure flavonolignans from silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res. 65: 4448-4456 (2005).
30. M. Pliskova, J. Yondracek, V. Kren, R. Guzak, P. Sedmera, D. Walterova, J. Psotava, V. Simanek, and M. Machala. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation. Toxicology 80: 215-230 (2005).
31. Deutsches Arzneibuch 10. (DAB 10.) 1991 Nachtrag, 1993, Band 3. Monographie über Mariendinstelfrüchte
32. Sz. Nyiredy, K. Dallenbach-Tölke, and O. Sticher. The PRISMA optimization system in planar chromatography. J. Planar Chromatogr. 1: 336- Page numbers required for publication. (1988).
33. Sz. Nyiredy, W. Wosniok, H. Thiele, and O. Sticher. PRISMA model for computer-aided HPLC mobile phase optimization based on an automatic peak identification approach. J. Liquid Chromatogr. 14: 3077 (1991).
34. S. Antus, K. Gulácsi, T. Kurtán, E. Baitz-Gács, Z. Szücs, and Zs. Fatér. Unpublished results.